According to FutureWise analysis the Ibuprofen API Market in 2023 was US$ 7.5 billion, and is expected to reach US$ 9.5 billion by 2031 at a CAGR of 3.5%. Market growth is driven by rising demand for over-the-counter (OTC) pain relief medications and the increasing prevalence of chronic pain and inflammation. Additionally, expanding pharmaceutical manufacturing in emerging economies and the ongoing use of ibuprofen in combination therapies contribute to this growth.

Ibuprofen is a white crystalline powder known chemically as 2-(4-isobutylphenyl) propionic acid, with the molecular formula C13H18O2. Ibuprofen serves as the active pharmaceutical ingredient (API) in a range of formulations, including tablets, capsules, and syrups. It is widely utilized for its effectiveness across these different delivery methods. It belongs to a class of medications called non-steroidal anti-inflammatory drugs (NSAIDs), which are effective for relieving pain, reducing fever, and decreasing inflammation.

The mechanism of action of ibuprofen involves the inhibition of prostaglandins, which are chemical messengers in the body responsible for signaling pain, fever, and inflammation. By lowering the levels of these chemicals, ibuprofen helps alleviate discomfort and diminish inflammation. It is available in both prescription and over-the-counter forms and is used to treat a range of conditions, such as headaches, menstrual cramps, toothaches, arthritis, and fever.

While ibuprofen is effective for many individuals, it is important to use it cautiously due to potential side effects. These can include stomach upset, gastrointestinal bleeding, and kidney damage. The medication is typically administered orally in the form of tablets, capsules, or liquid suspensions. After ingestion, ibuprofen is rapidly absorbed in the gastrointestinal tract, achieving peak plasma concentrations within 1-2 hours.

FutureWise Market Research has published a report that provides an insightful analysis of Ibuprofen API Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=8924&type=requestsample

Ibuprofen API Market Segmentation:

By Product

• Rx
• OTC

By Application

• Headache
• Arthritis
• Others

By End User

• CROs and CMOs
• Biopharmaceutical and Pharmaceutical Companies
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Ibuprofen API Market:

• BASF SE
• Biocause Inc
• IOL Chemicals And Pharmaceuticals Limited
• SI Group, Inc
• Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd
• Solara Active Pharma Sciences Limited.
• Dr. Reddy's Laboratories Ltd
• Strides Pharma Science Limited
• SX Pharma
• Granules India Limited
• Rochem International Inc.
• Octavius Pharma Pvt. Ltd
• Athenex, Inc.
• Teva Pharmaceutical Industries Ltd
• Cipla Inc.
• Aurobindo Pharma
• Fresenius Kabi AG

Recent developments by key players in Ibuprofen API Market:

Solara Active Pharma Sciences Limited.

• In November 2022, the advanced, multipurpose API production facility owned by Solara Active Pharma Sciences Limited in Vishakhapatnam, Andhra Pradesh, received Certificate of Suitability (CEP) approval from the European Directorate for the Quality of Medicine (EDQM) for the manufacture of Ibuprofen API.

IOL Chemicals And Pharmaceuticals Limited

• Achieved the EDQM certificate in May 2023, which further enhances its credibility and access to international markets.
• IOLCP offers a diverse range of APIs, including Ibuprofen, Metformin HCL, Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Lamotrigine, Losartan Potassium, Levetiracetam, Paracetamol, Fenofibrate (Micronised), and Gabapentin.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=8924&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Ibuprofen API Market By Product, By Application, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com